• Title/Summary/Keyword: healthcare roadmap

Search Result 8, Processing Time 0.016 seconds

How to Integrate the Fourth Industrial Revolution in the Healthcare Industry? (보건의료분야에서 4차산업혁명, 어떻게 대처할 것인가?)

  • Sun-Hee Lee
    • Health Policy and Management
    • /
    • v.33 no.1
    • /
    • pp.1-2
    • /
    • 2023
  • As the industrial paradigm shift, often condensed as the "4th Industrial Revolution," gains momentum, there is a growing need to actively introduce digital healthcare into the medical field. The new administration announced its commitment to become a global leader in the biohealth and digital healthcare sector. To fulfill this pledge, preemptive policy leadership and attention from the government are required. The recent issue of legislating non-face-to-face medical care suggests that introducing digital healthcare goes beyond simply adopting new technologies. Incorporating digital healthcare involves changing the existing healthcare delivery process and coordinating the roles of stakeholders. To successfully change the structure of the medical industry, a mid- to long-term roadmap should be meticulously organized and promoted. Policy efforts are needed to resolve conflicts and lead to compromises through continuous communication with interest groups.

A Strategy Toward Reconstructing the Healthcare System of a Unified Korea

  • Lee, Yo Han;Yoon, Seok-Jun;Kim, Seok Hyang;Shin, Hyun-Woung;Lee, Jin Yong;Kim, Beomsoo;Kim, Young Ae;Yoon, Jangho;Shin, Young Seok
    • Journal of Preventive Medicine and Public Health
    • /
    • v.46 no.3
    • /
    • pp.134-138
    • /
    • 2013
  • This road map aims to establish a stable and integrated healthcare system for the Korean Peninsula by improving health conditions and building a foundation for healthcare in North Korea through a series of effective healthcare programs. With a basic time frame extending from the present in stages towards unification, the roadmap is composed of four successive phases. The first and second phases, each expected to last five years, respectively, focus on disease treatment and nutritional treatment. These phases would thereby safeguard the health of the most vulnerable populations in North Korea, while fulfilling the basic health needs of other groups by modernizing existing medical facilities. Based on the gains of the first two phases, the third phase, for ten years, would prepare for unification of the Koreas by promoting the health of all the North Korean people and improving basic infrastructural elements such as health workforce capacity and medical institutions. The fourth phase, assuming that unification will take place, provides fundamental principles and directions for establishing an integrated healthcare system across the Korean Peninsula. We are hoping to increase the consistency of the program and overcome several existing concerns of the current program with this roadmap.

MDA 기반 J2EE 시스템 구축

  • 류형규
    • Proceedings of the CALSEC Conference
    • /
    • 2002.01a
    • /
    • pp.448-453
    • /
    • 2002
  • ☆1990년대 Object Management Architecture(OMA)활동 초기10년간 Roadmap 제공(CORBA) 1997년 UML 표준작성 MOF, XMI, CWM 등의 기술 확장 ☆OMG의 향후 방향 →Model Driven Architecture MDA를 통한 OMG 플랫폼 기술완성(UML과 CORBA를 포함한) OMG의 proven, neutral, open standardization 프로세서 사용 OMG의 Vertical Market에 대한 직접적인 지원(Healthcare, finance, telecommunications, life sciences research, manufacturing등)(중략)

  • PDF

ICT Convergence Healthcare Services Status and Future Strategies (ICT융합 헬스케어 서비스 현황 및 발전전략)

  • Lee, Tae-Gyu
    • Asia-pacific Journal of Multimedia Services Convergent with Art, Humanities, and Sociology
    • /
    • v.7 no.10
    • /
    • pp.865-878
    • /
    • 2017
  • To realize the healthy life of human, mental, physical, and environmental factors must be managed continuously and stably. In order to manage human health, the 21st century healthcare field is essential ongoing interactions and convergence with ICT technologies. Such demands have created a convergence of technologies (fusion technology) in combination with the heterogeneous technologies. And, with the convergence of medical technology and ICT technologies, the development of personalized therapy environments is created. Advances in ICT-converged healthcare services are progressing due to the development of diverse wearable devices. Such ICT fusion system is exponentially increasing the complexity of the ICT convergence healthcare system and is resulting in various technical, institutional, environmental, and cultural issues. This study explores the status of developments in ICT healthcare technologies from the past to date, identifies major technology and policy issues to address these challenges. Finally it will recommend healthcare policies and a future road-map.

Lifelog Analysis and Future using Artificial Intelligence in Healthcare (헬스케어에서 인공지능을 활용한 라이프로그 분석과 미래)

  • Park, Minseo
    • The Journal of the Convergence on Culture Technology
    • /
    • v.8 no.2
    • /
    • pp.1-6
    • /
    • 2022
  • Lifelog is a digital record of an individual collected from various digital sensors, and includes activity amount, sleep information, weight change, body mass, muscle mass, fat mass, etc. Recently, as wearable devices have become common, a lot of high-quality lifelog data is being produced. Lifelog data shows the state of an individual's body, and can be used not only for individual health care, but also for causes and treatment of diseases. However, at present, AI/ML-based correlation analysis and personalization are not reflected. It is only at the level of presenting simple records or fragmentary statistics. Therefore, in this paper, the correlation/relationship between lifelog data and disease, and AI/ML technology inside lifelog data are examined, and furthermore, a lifelog data analysis process based on AI/ML is proposed. The analysis process is demonstrated with the data collected in the actual Galaxy Watch. Finally, we propose a future convergence service roadmap including lifelog data, diet, health information, and disease information.

Is it too Audacious to Challenge: Roadmap for a Primetime of Clinical Pharmacy in Korea (한국 임상약학은 어디로 달려가는가?: 한국 임상약학 발전을 위한 제안서)

  • Min, Bo-kyung
    • Korean Journal of Clinical Pharmacy
    • /
    • v.21 no.2
    • /
    • pp.182-187
    • /
    • 2011
  • The Korean pharmacy education has been facing extraordinary challenges. Clinical pharmacy has been embraced into mainstream in the new curriculum since its introduction in Korea. Although these changes are positive to provide our graduates adequate knowledge and skills to meet international standards of pharmacy education, current preparedness is far from desired goals. Thus, faculty members and clinical pharmacy experts from diverse walks are tirelessly committed to develop clinically oriented educational sites. However, it is important to recognize that pharmacy practice, research, and education should be aligned with the $Profession^{\circ}{\Phi}s$ vision. Most faculty members in clinical pharmacy were unexceptionally expected to tackle educational challenges with new curriculum. All academicians must profess throughout their career. Fundamental component in academic career is research accomplishments. The prosperity of clinical pharmacy inevitably goes with research. Clinical researchers in Korea are underprivilaged over basic scientists due to less funding opportunity, administrative support, and research resources. Clinical pharmacy researchers should further overcome poor recognition among other healthcare professionals and government. Aggressive networking and support and awareness of pharmacy oriented clinical research from the Korean college of clinical pharmacy would nurture clinical pharmacy research. With research progress, clinical pharmacy would be prerogative in Korean pharmacy advance.

Conclusions and Suggestions on Low-Dose and Low-Dose Rate Radiation Risk Estimation Methodology

  • Sakai, Kazuo;Yamada, Yutaka;Yoshida, Kazuo;Yoshinaga, Shinji;Sato, Kaoru;Ogata, Hiromitsu;Iwasaki, Toshiyasu;Kudo, Shin'ichi;Asada, Yasuki;Kawaguchi, Isao;Haeno, Hiroshi;Sasaki, Michiya
    • Journal of Radiation Protection and Research
    • /
    • v.46 no.1
    • /
    • pp.14-23
    • /
    • 2021
  • Background: For radiological protection and control, the International Commission on Radiological Protection (ICRP) provides the nominal risk coefficients related to radiation exposure, which can be extrapolated using the excess relative risk and excess absolute risk obtained from the Life Span Study of atomic bomb survivors in Hiroshima and Nagasaki with the dose and dose-rate effectiveness factor (DDREF). Materials and Methods: Since it is impossible to directly estimate the radiation risk at doses less than approximately 100 mSv only from epidemiological knowledge and data, support from radiation biology is absolutely imperative, and thus, several national and international bodies have advocated the importance of bridging knowledge between biology and epidemiology. Because of the accident at the Tokyo Electric Power Company (TEPCO)'s Fukushima Daiichi Nuclear Power Station in 2011, the exposure of the public to radiation has become a major concern and it was considered that the estimation of radiation risk should be more realistic to cope with the prevailing radiation exposure situation. Results and Discussion: To discuss the issues from wide aspects related to radiological protection, and to realize bridging knowledge between biology and epidemiology, we have established a research group to develop low-dose and low-dose-rate radiation risk estimation methodology, with the permission of the Japan Health Physics Society. Conclusion: The aim of the research group was to clarify the current situation and issues related to the risk estimation of low-dose and low-dose-rate radiation exposure from the viewpoints of different research fields, such as epidemiology, biology, modeling, and dosimetry, to identify a future strategy and roadmap to elucidate a more realistic estimation of risk against low-dose and low-dose-rate radiation exposure.